All posts
-
Press Releases — June 2, 2022C2i Genomics and Karkinos Healthcare Partner to Bring AI-Powered Cancer Detection and Monitoring to India
-
Press Releases — April 6, 2022
C2i Genomics Launches C2inform MRD Test to Bring Distributed Cancer Monitoring to Cancer Centers Across Europe
-
Press Releases — February 28, 2022
C2i Genomics Applauded by Frost & Sullivan for Enabling Real-time Cancer Monitoring Using Genomic Data with Its C2intelligence Platform
The C2intelligence Platform enables custom, cost-effective, efficient, automatic, and globally accessible cancer data management and real-time monitoring. SAN ANTONIO...
-
Press Releases — February 8, 2022
C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for...
-
Press Releases — January 16, 2022
C2i Genomics Partners with OncoDNA to Bring AI-Powered Liquid Biopsy for Cancer Diagnostics Across Europe
-
Press Releases — December 8, 2021
C2i Genomics Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
-
Press Releases — October 26, 2021
C2i Genomics is Globalizing AI-Based Cancer Diagnostics and Monitoring | BioSpace
-
Press Releases — October 13, 2021
C2i Genomics Expands AI-Powered Cancer Detection and Monitoring Capabilities in US and China Through Partnership with NuProbe | WebWire
-
Press Coverage — August 12, 2021
C2i Genomics Appoints Chief Medical Officer to Scale Its AI-Powered Cancer Detection Platform Globally | WebWire
-
Press Releases — July 20, 2021
C2i Genomics and Premier Inc. Team Up to Bring AI-Powered Personalized Cancer Detection and Treatment Monitoring to U.S. Healthcare Providers
